Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.

Enlivex Therapeutics Ltd.

We’ve identified three of the best cheap stocks to buy today. Price is important to us all, especially during tough economic times. That is true in...

3 Best Cheap Stocks to Buy Now: 04/29/26

Enlivex ( ($ENLV) ) has issued an update. On April 8, 2026, Enlivex announced that Ondo Finance has launched ENLVon, a tokenized representation of ...

Market Cap	$199.11M	P/E Ratio	N/A
52W High	$2.10	52W Low	$0.66
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	N/A	52W Position	10.8%
Overall Score	37	Value Score	80
Quality Score	23	Technical Score	10

EPS Current Est	$-0.08	EPS Next Est	$-0.09
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ENLV	$0.82	-0.46%	283.21K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ENLV	$0.82	-0.5%	283.21K
3
4
5
6

ENLV

ENLV

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Enlivex Therapeutics Ltd. Data in Excel

Get Enlivex Therapeutics Ltd. Data in Excel